Color Stock
Genomic Testing Company
Sign up today and learn more about Color Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Color Stock
Color is a population health technology company that aims to enable the delivery of advanced healthcare through clinical genetics. Color’s Population Genomics Platform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. A select list of Color’s partners includes NorthShore University Health System, the National Institutes of Health (NIH), Ochsner Health System, Verily, Apple, Visa, Levi Strauss, and Salesforce.
Color was founded by Othman Laraki in 2015 and is based in Burlingame, California. Notable investors include T. Rowe Price, Viking Global Investors, and General Catalyst.
Investors
CRV
DoorDash, Airtable, Bird, Fair, Cybereason, Twitter, Niantic, ClassPass, Recursion Pharmaceuticals, Freenome
Emerson Collective
Devoted Health, Carbon, Deel, Guild Education, Handshake, Color, Boom Supersonic, Aurora Solar, Udacity, The Athletic
General Catalyst Partners
Snap, Jet, Stripe, Anduril Industries, Devoted Health, Lacework, Relativity Space, Oscar Health, Circle, Hopin
LeFrak
Blink Health, Color, Qualia, OpenGov, PeerStreet, Common Living, Juniper Square, MakeSpace
LionTree Partners
Pegasus Tech Ventures
Bird, Roofstock, Color, Lark, Data.ai, Tamr, Bellabeat, ThirdLove, Osaro, IFTTT
Shasta Ventures
Dollar Shave Club, Tonal, Highspot, Turo, Nextdoor, Color, Lattice, Anaplan, Imperfect Foods, Zuora
T. Rowe Price
One97, Flipkart, WeWork, Cruise, Airbnb, Rivian, Magic Leap, Nuro, Caris Life Sciences, Vroom
Viking Global Investors
Impossible Foods, Moderna Therapeutics, Apeel Sciences, Adaptive Biotechnologies, Arctic Wolf, Talkdesk, Druva, Color, Clip, Iterable
Funding History
| April 2015 | $22.5M |
|---|---|
| August 2016 | $47.4M |
| August 2017 | $20.0M |
| August 2017 | $69.4M |
| December 2020 | $67.2M |
| December 2020 | $89.5M |
| October 2021 | $100.0M |
Management
Chief Executive Officer
Othman Laraki
Chief Financial Officer
Michael Herring
Press
prnewswire - May, 31 2022
Color Health Adds Ann Mather and Luis Borgen to Board Of Directorsfiercehealthcare - Nov, 9 2021
Health tech firm Color pockets $100M to build out healthcare services in post-pandemic markettrib - Nov, 9 2021
From genetic testing to public health, Color now valued at $4.6Bmobihealthnews - Nov, 9 2021
Population health platform Color nabs $100Mvator - Jan, 14 2021
Podcast call with Color CEO Othman Larakidlvr - Jan, 8 2021
Color: $167 Million Series D Funding And $1.5 Billion Valuationzpr - Jan, 6 2021
Color announces $167 million in Series D financing to help build public health infrastructure across the U.S.TechCrunch - Sep, 14 2020
Carbon Health and Color founders see power in bringing healthcare to the edgefiercebiotech - May, 20 2020
Color gets green light for LAMP-based COVID-19 screening testaxial - Apr, 28 2020
Case study on ColorGenome Web - Jan, 10 2020
Color Partners With Sanford Health on Clinical Genomicsbusinessinsider - Aug, 22 2019
We spoke with the CEO of Color about what its new genetic counseling project with NIH means to the companyEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
